# RuPHOTACs Provide Photocontrol Over Protein Degradation with Optimized Properties for Biological Applications

**Authors:** Dmytro Havrylyuk, Ainsley LaMore, Majd Al Hamaly, Jessica S. Blackburn, David K. Heidary, Edith C. Glazer

PMC · DOI: 10.21203/rs.3.rs-8483849/v1 · Research Square · 2026-02-10

## TL;DR

This paper introduces RuPHOTACs, a new type of light-controlled molecule that improves the precision and effectiveness of protein degradation in cells.

## Contribution

The novel use of Ru(II) photocages in PROTACs enables precise light-controlled protein degradation with enhanced selectivity and in vivo efficacy.

## Key findings

- RuPHOTACs showed high selectivity for light-triggered activation and improved potency against target proteins.
- The system effectively reduced levels of c-MYC and PIM1 in cells using low energy red light.
- A new reporter system using Dendra2 fusion proteins accurately measures protein degradation rates in live cells.

## Abstract

PROteolysis TArgeting Chimeras (PROTACs) are bifunctional molecules that catalyze degradation of selected proteins by inducing protein:protein interactions (PPIs) between E3 ubiquitin ligases and the protein of interest. A critical limitation is undesired effects in untargeted tissues, necessitating approaches to impose spatiotemporal control over PROTAC function. Here we present Ru(II) photocages that can be released with low energy light, providing triggered PROTAC activity on demand. The systems, termed Ruthenium-based PHOToActivated Chimeras (RuPHOTACs), were validated by targeting bromodomain-containing proteins, which act as crucial epigenetic regulators, and also strongly reduced levels of c-MYC and PIM1. The novel RuPHOTACs demonstrate that the incorporation of metal components within organic PROTACs confers multiple advantages for light-controlled systems for chemical biology applications, including the highest selectivity for activation in the light vs. the dark, improved potency against the target proteins of interest, and increased efficacy in vivo using low energy red light. To efficiently monitor protein degradation via optical means, a new strategy was implemented by creating a fusion of a photoconvertible protein, Dendra2, with the proteins of interest. This bifunctional reporter system for live cell analysis decouples protein degradation efficiency and rates from signals arising from new protein production, and is superior to prior reporter systems described for PROTACs because it directly measures the true degradation rate of the target protein in intact, viable cells while simultaneously tracking newly synthesized protein without perturbing translation, proteostasis, or cell health.

## Linked entities

- **Genes:** MYC (MYC proto-oncogene, bHLH transcription factor) [NCBI Gene 4609], PIM1 (Pim-1 proto-oncogene, serine/threonine kinase) [NCBI Gene 5292]

## Full-text entities

- **Genes:** DNER (delta/notch like EGF repeat containing) [NCBI Gene 92737] {aka UNQ26, bet}, BRD2 (bromodomain containing 2) [NCBI Gene 6046] {aka BRD2-IT1, D6S113E, FSH, FSHRG1, FSRG1, NAT}, ESR1 (estrogen receptor 1) [NCBI Gene 2099] {aka ER, ESR, ESRA, ESTRR, Era, NR3A1}, BRD3 (bromodomain containing 3) [NCBI Gene 8019] {aka FSHRG2, ORFX, RING3L}, PTK2B (protein tyrosine kinase 2 beta) [NCBI Gene 2185] {aka CADTK, CAKB, FADK2, FAK2, PKB, PTK}, CRBN (cereblon) [NCBI Gene 51185] {aka MRT2, MRT2A}, BTK (Bruton tyrosine kinase) [NCBI Gene 695] {aka AGMX1, AT, ATK, BPK, IGHD3, IMD1}, FKBP1AP4 (FKBP prolyl isomerase 1A pseudogene 4) [NCBI Gene 2285] {aka FKBP12, FKBP1P4}, GAPDH (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 2597] {aka G3PD, GAPD, HEL-S-162eP}, AR (androgen receptor) [NCBI Gene 367] {aka AIS, AR8, DHTR, HPCX3, HUMARA, HYSP1}, AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 207] {aka AKT, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA}, BRD4 (bromodomain containing 4) [NCBI Gene 23476] {aka CAP, CDLS6, FSHRG4, HUNK1, HUNKI, MCAP}, MYC (MYC proto-oncogene, bHLH transcription factor) [NCBI Gene 4609] {aka MRTL, MYCC, bHLHe39, c-Myc}, PIM1 (Pim-1 proto-oncogene, serine/threonine kinase) [NCBI Gene 5292] {aka PIM}, DDB1 (damage specific DNA binding protein 1) [NCBI Gene 1642] {aka DDBA, UV-DDB1, WHIKERS, XAP1, XPCE, XPE}
- **Diseases:** Cytotoxicity (MESH:D064420), brainstem tumor (MESH:D020295), tumorigenic (MESH:D002471), DIPG (MESH:D000080443), solid (MESH:D018250), deformities (MESH:D009140), cancer (MESH:D009369), hypoxia (MESH:D000860), phototoxicity (MESH:D017484)
- **Chemicals:** amines (MESH:D000588), MgSO4 (MESH:D008278), Lipofectamine 2000 (MESH:C086724), tetracycline (MESH:D013752), Penicillin (MESH:D010406), Ruthenium (MESH:D012428), carboplatin (MESH:D016190), nitriles (MESH:D009570), pyridine (MESH:C023666), 3MLCT (-), Tricaine-S (MESH:C003636), DMSO (MESH:D004121), cycloheximide (MESH:D003513), hydrogen (MESH:D006859), KCl (MESH:D011189), Tween 20 (MESH:D011136), PBS (MESH:D007854), thiophene (MESH:D013876), PEG4 (MESH:C000619859), sodium pyrophosphate (MESH:C003319), cyclopentadiene (MESH:D003517), CO2 (MESH:D002245), [2,2'-biquinoline]-4,4'-dicarboxylic acid (MESH:C047117), resazurin (MESH:C005843), pomalidomide (MESH:C467566), bis-tris (MESH:C026272), BZT (MESH:C004518), Streptomycin (MESH:D013307), alanine (MESH:D000409), CH3CN (MESH:C032159), polyethylene glycol (MESH:D011092), EDTA (MESH:D004492), NP40 (MESH:C010615), ferrocene (MESH:C004998), oxygen (MESH:D010100), thioether (MESH:D013440), blasticidin (MESH:C004500), formic acid (MESH:C030544), 3MC (MESH:D008748), Methanol (MESH:D000432), Sodium Deoxycholate (MESH:D003840), NaCl (MESH:D012965), Pt (MESH:D010984), metal (MESH:D008670), 13C (MESH:C000615229), Gly (MESH:D005998), pyrimidine (MESH:C030986), 2,2';6',2"-terpyridine (MESH:C517923), 2,2'-biquinoline (MESH:C419881), thalidomide (MESH:D013792), CaCl2 (MESH:D002122), NaF (MESH:D012969), BTZ (MESH:D000069286), methylene blue (MESH:D008751), hygromycin B. (MESH:D006921), amide (MESH:D000577), imidazole (MESH:C029899), azobenzene (MESH:C009850), water (MESH:D014867)
- **Species:** Homo sapiens (human, species) [taxon 9606], Danio rerio (leopard danio, species) [taxon 7955]
- **Mutations:** C481S, serine/threonine, G1311A
- **Cell lines:** HEK — Homo sapiens (Human), Transformed cell line (CVCL_0045), PHOTAC-I-3 — Homo sapiens (Human), Embryonic stem cell (CVCL_C376), HEK Flp-In — Homo sapiens (Human), Transformed cell line (CVCL_U006), BRD-D2 — Homo sapiens (Human), Chronic myelogenous leukemia, BCR-ABL1 positive, Cancer cell line (CVCL_SF54), S25 — Mus musculus (Mouse), Hybridoma (CVCL_G585), SF8628 — Homo sapiens (Human), Diffuse intrinsic pontine glioma, Cancer cell line (CVCL_IT46), CRL-1596 — Homo sapiens (Human), Glioblastoma, Cancer cell line (CVCL_B4FW), Ramos — Homo sapiens (Human), Burkitt lymphoma, Cancer cell line (CVCL_0597)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12919169/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12919169/full.md

## References

59 references — full list in the complete paper: https://tomesphere.com/paper/PMC12919169/full.md

---
Source: https://tomesphere.com/paper/PMC12919169